Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Philosophical transactions of the Royal Society of London. Series B, Biological sciences

• Publication date

  1999-06-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1098/RSTB.1999.0466PMID 10434313PMCID PMC1692614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

  2004cited by this paper
• Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease

  2004cited by this paper
• Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• The tauopathies: toward an experimental animal model.

  1999cited by this paper
• High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

  1999cited by this paper
• Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.

  1999cited by this paper
• FTDP‐17 mutations N279K and S305N in tau produce increased splicing of exon 10

  1999cited by this paper
• Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.

  1999cited by this paper
• Tau pathology in a family with dementia and a P301L mutation in tau.

  1999cited by this paper
• Tau gene mutation in familial progressive subcortical gliosis

  1999cited by this paper
• Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17.

  1999cited by this paper
• NMR STRUCTURE OF TAU EXON 10 SPLICING REGULATORY ELEMENT RNA

  1999cited by this paper
• A distinct familial presenile dementia with a novel missense mutation in the tau gene.

  1999cited by this paper
• Tau mutations cause frontotemporal dementias.

  1998influential reference
• Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

  1998cited by this paper
• Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau.

  1998influential reference
• Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease

  1998cited by this paper
• Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Lewy body diseases and multiple system atrophy as alpha-synucleinopathies.

  1998cited by this paper
• Alzheimer's disease.

  1998cited by this paper
• Genetic classification of primary neurodegenerative disease.

  1998cited by this paper
• Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity

  1998cited by this paper
• Synthetic filaments assembled from C‐terminally truncated α‐synuclein

  1998cited by this paper
• Lesson of the week: Pneumatic compression boots for prophylaxis against deep vein thrombosis: beware occult arterial disease

  1998cited by this paper
• Tau protein pathology in neurodegenerative diseases.

  1998cited by this paper
• Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

  1998influential reference
• α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

  1998cited by this paper
• Multiple-system atrophy: a new α-synuclein disease?

  1998cited by this paper
• Neuron loss in APP transgenic mice

  1998cited by this paper
• Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?

  1998cited by this paper
• The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”)

  1998cited by this paper
• Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

  1998cited by this paper
• Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

  1998cited by this paper
• Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

  1998cited by this paper
• Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

  1998cited by this paper
• NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998influential reference
• Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution.

  1998cited by this paper
• New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry

  1998cited by this paper
• Filamentous nerve cell inclusions in neurodegenerative diseases.

  1998influential reference
• Tau is a candidate gene for chromosome 17 frontotemporal dementia

  1998influential reference
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

  1998cited by this paper
• Effect of heparin on phosphorylation site specificity of neuronal Cdc2‐like kinase

  1998cited by this paper
• Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism.

  1998cited by this paper
• Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.

  1998cited by this paper
• Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

  1998cited by this paper
• Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation

  1998cited by this paper
• Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes*

  1998cited by this paper
• Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.

  1998cited by this paper
• Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation*

  1998influential reference
• Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.

  1998cited by this paper
• RNA sequestration to pathological lesions of neurodegenerative diseases

  1998cited by this paper
• Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

  1998cited by this paper
• Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy.

  1998cited by this paper
• Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Multiple-system atrophy: a new alpha-synuclein disease?

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

  1998cited by this paper
• Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies

  1998influential reference
• Synthetic ¢laments assembled from C-terminally truncated K-synuclein

  1998cited by this paper
• Lewy body diseases and multiple system atrophy as α-synucleinopathies

  1998cited by this paper
• Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

  1998influential reference
• Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse

  1997cited by this paper
• Role of glycosaminoglycans in determining the helicity of paired helical filaments.

  1997cited by this paper
• Changes in the ageing brain in health and disease.

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Two‐Dimensional Characterization of Paired Helical Filament‐Tau from Alzheimer's Disease: Demonstration of an Additional 74‐kDa Component and Age‐Related Biochemical Modifications

  1997cited by this paper
• Familial Parkinson's disease. The awakening of alpha-synuclein.

  1997cited by this paper
• Familial Parkinson's disease: The awakening of α-synuclein

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997cited by this paper
• Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Autosomal dominant dementia with widespread neurofibrillary tangles

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997influential reference
• NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

  1997cited by this paper
• APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

  1997cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference

  1997cited by this paper
• Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases

  1997cited by this paper
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997cited by this paper
• Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

  1997influential reference
• Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ.

  1997cited by this paper
• Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons

  1997cited by this paper
• Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques

  1997cited by this paper
• Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles

  1996cited by this paper
• RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments

  1996cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction.

  1996cited by this paper
• Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.

  1996cited by this paper

• Neurobehavioral Testing as Cognitive Function Evaluation tool in Experimentally Induced Neurodegeneration in Mice

  2024cites this paper
• Impairment of Nrf2 signaling in the hippocampus of P301S tauopathy mice model aligns with the cognitive impairment and the associated neuroinflammation

  2024cites this paper
• Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins

  2024cites this paper
• Amyloid-Induced Neurodegeneration: A Comprehensive Review through Aggregomics Perception of Proteins in Health and Pathology.

  2024cites this paper
• Characterization of Intrinsically Disordered Proteins in Healthy and Diseased States by Nuclear Magnetic Resonance.

  2024cites this paper
• Model-Dependent Solvation of the K-18 Domain of the Intrinsically Disordered Protein Tau.

  2023cites this paper
• Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson’s disease

  2022cites this paper
• Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again.

  2022cites this paper
• Different Roles of p62 (SQSTM1) Isoforms in Keratin-Related Protein Aggregation

  2021cites this paper
• Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease

  2021cites this paper
• Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation

  2020cites this paper
• Psychiatric Disorders in Dementia

  2020cites this paper
• Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and ageing mice

  2020cites this paper
• Folding Free-Energy Landscape of α-Synuclein (35-97) Via Replica Exchange Molecular Dynamics.

  2020cites this paper
• Oxidative stress-induced parkin misfolding, aggregation, and toxicity

  2020cites this paper
• Interaction of Alpha-Synuclein and its Mutants with Rigid Lipid Vesicle Mimics of Varying Surface Curvature.

  2020cites this paper
• GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy

  2020cites this paper
• Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice

  2020cites this paper
• α‐synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease

  2020cites this paper
• In vitro study of the mechanism of intraneuronal β-amyloid aggregation in Alzheimer’s disease

  2020cites this paper
• Characterizing the inhibition of α‐synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP

  2019cites this paper
• In-vitro and in-silico investigation of protective mechanisms of crocin against E46K α-synuclein amyloid formation

  2019cites this paper
• Neuroimmunological phenomena involved in chronic traumatic brain injury

  2019cites this paper
• Neuropathology and muscle biopsy techniques

  2019cites this paper
• Understanding mechanistic regulation of Hsp70 and Hsp90 in neurodegenerative diseases.

  2019cites this paper
• [18F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP

  2018cites this paper
• Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins.

  2018cites this paper
• Structural characteristics and membrane interactions of tandem α-synuclein oligomers

  2018cites this paper
• Clinical and Pathological Implications

  2017cites this paper
• Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism

  2017cites this paper
• The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases

  2017cites this paper
• Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development.

  2017cites this paper
• α-Synuclein-Related Synaptic Pathology: Novel Clues for Parkinson’s Disease Therapy

  2017cites this paper
• Noradrenergic Modulation of Cognition in Health and Disease

  2017cites this paper
• Organic Disorders of the Brain

  2016cites this paper
• Les troubles olfactifs au cours de la sénescence et de deux principales pathologies neurodégénératives

  2016cites this paper
• Neurodegenerative disorders share common features of "loss of function" states of a proposed mechanism of nervous system functions.

  2016cites this paper
• Oxidative Stress, Metabolic Syndrome and Alzheimer’s Disease

  2016cites this paper
• Neurological Disorders and Related Problems in the Elderly

  2016cites this paper
• Untangling the Manganese-α-Synuclein Web

  2016cites this paper
• Modulation of the expression and function of dopaminergic presynaptic proteins by the statins : Potential implication for the therapeutic intervention in Parkinson’s disease.

  2015cites this paper
• Alpha-synuclein amyloid accumulation and its interaction with prion protein

  2015cites this paper
• Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders

  2015cites this paper
• Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast

  2015cites this paper
• Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice

  2015cites this paper
• A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression

  2015cites this paper
• The triple power of D³: protein intrinsic disorder in degenerative diseases.

  2014cites this paper
• The Effect of Acute LPS-Induced Immune Activation and Brain Insulin Signaling Disruption in a Diabetic Model of Alzheimer's Disease

  2014cites this paper
• Fundamentals of Protein Folding

  2014cites this paper
• Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases

  2014cites this paper
• Contrôle de l'activation microgliale par les lymphocytes T dans un modèle murin de neurodégénérescence induite par la 6-OHDA

  2014cites this paper
• Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease.

  2013cites this paper
• Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.

  2013cites this paper
• Multiple System Atrophy and Parkinson ’ s disease

  2013cites this paper
• Biophysics of Parkinson’s Disease: Structure and Aggregation of α -Synuclein

  2013cites this paper
• Distinct β-sheet structure in protein aggregates determined by ATR-FTIR spectroscopy.

  2013cites this paper
• Under‐folded proteins: Conformational ensembles and their roles in protein folding, function, and pathogenesis

  2013cites this paper
• Pathogenesis of neurodegenerative diseases via templated recruitment

  2013cites this paper
• Amyloid Peptide Self-Assembly in Protic Ionic Liquids

  2013cites this paper
• The function of α-synuclein.

  2013cites this paper
• Techniques in neuropathology

  2013cites this paper
• Alpha-synuclein in the neurodegenerative mechanisms of Parkinson's disease and dementia with Lewy bodies

  2012cites this paper
• Targeting the Chameleon: a Focused Look at α-Synuclein and Its Roles in Neurodegeneration

  2012cites this paper
• Subventricular Zone Under the Neuroinflammatory Stress and Parkinson’s Disease

  2012cites this paper
• Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability*

  2012cites this paper
• 7 Targeting α-Synuclein-Related Synaptic Pathology : Novel Clues for Parkinson ’ s Disease Therapy

  2012cites this paper
• α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.

  2012cites this paper
• Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases

  2012cites this paper
• Evolutional Aspects of Alzheimer's Disease Pathogenesis

  2012cites this paper
• Intrinsically Disordered Chaperones and Neurodegeneration

  2011cites this paper
• Characterization of the non-fibrillar α-synuclein oligomers.

  2011cites this paper
• Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau

  2011influential citation
• Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells

  2011cites this paper
• Targeting α-Synuclein-Related Synaptic Pathology: Novel Clues for Parkinson’s Disease Therapy

  2011cites this paper
• Inflammation in the early stages of neurodegenerative pathology.

  2011cites this paper
• Flexible nets of malleable guardians: intrinsically disordered chaperones in neurodegenerative diseases.

  2011cites this paper
• Functional Aspects of Redox Control During Neuroinflammation

  2010cites this paper
• Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model

  2010influential citation
• Insight Into Parkinson's Disease: Does alpha-Synuclein Use the MVB/Endocytosis Pathway as a Route for Degradation in the Lysosome?

  2010cites this paper
• 3, 4-Dihydroxyphenylacetic Acid (DOPAC) impairs α-synuclein interaction with lipids

  2010cites this paper
• Protein disorder in the human diseasome: unfoldomics of human genetic diseases

  2009cites this paper
• Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.

  2009influential citation
• Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.

  2009cites this paper
• DISCopathies: Brain Disorders Related to DISC1 Dysfunction

  2009cites this paper
• Nanotechnology, Nanostructure, and Nervous System Disorders

  2009cites this paper
• Intrinsic disorder in proteins associated with neurodegenerative diseases.

  2009cites this paper
• Unfoldomics of human diseases: linking protein intrinsic disorder with diseases

  2009cites this paper
• Synucleins and their roles in the pathology of Parkinson’s disease as metal binding proteins

  2009cites this paper
• Techniques in Neuropathology

  2008cites this paper
• Alpha-synuclein misfolding and neurodegenerative diseases.

  2008cites this paper
• Co-expression of FTDP-17 Human Tau and GSK-3ß (or APPSW) in Transgenic Mice: Induction of Tau Polymerization and Neurodegeneration

  2008cites this paper
• Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease

  2008cites this paper
• Amyloidogenesis of natively unfolded proteins.

  2008cites this paper
• Intrinsically disordered proteins in human diseases: introducing the D2 concept.

  2008cites this paper
• Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders.

  2008cites this paper
• Molecular and cellular biology of synucleins.

  2008cites this paper
• A cell culture model for investigation of Hirano bodies

  2008cites this paper
• Tauopathies

  2007cites this paper
• Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.

  2007cites this paper
• Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.

  2007cites this paper